0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query technavio global hemophilia b market 2015 2019 industry analysis.Your search for "" gave back 1533063 results.
ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Rare Hemophilia Factors market size was valued at US$ 196.9 million in 2023. With growing demand in downstream market, the Rare Hemophilia...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Hemophilia is a rare disorder in which your blood doesn't clot normally because it lacks sufficient blood-clotting proteins (clotting factors)...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Summary Hemophilia Treatment market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
June 2019
Price: USD 2,960.00
The global Eptacog Alfa (rFVIIa) market size was valued at USD 1224.5 million in 2023 and is forecast to a readjusted size of USD 1655.4 million by...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Bleeding Disorders market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment,...
Catalog:
HYR
May 2022
Price: USD 1,900.00
The global Recombinant Human Coagulation VIIa market size was valued at USD 1166.6 million in 2023 and is forecast to a readjusted size of USD 1488.4...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Recombinant human coagulation factor VIIa is a drug from Novo Nordisk for bleeding episodes and prevention of bleeding during surgical procedures or...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Eptacog Alfa (rFVIIa) market size was valued at US$ 1164.1 million in 2023. With growing demand in downstream market, the Eptacog Alfa (...
Catalog:
LPI
January 2024
Price: USD 3,660.00
A barcode label solution typically refers to a system or software that allows businesses to generate and print barcode labels for their products or...
Catalog:
MRRPB5
July 2023
Price: USD 2,900.00
